Transdel Pharmaceuticals, Inc. (OTC BB: TDLP)

Transdel Pharmaceuticals, Inc. (OTC BB: TDLP), a specialty pharmaceutical company, is dedicated to developing and commercializing non-invasive topically delivered medications. Ketotransdel, Transdel’s lead topical drug, leverages the company’s proprietary Transdel™ cream formulation to facilitate the passage of ketoprofen through the skin to reach underlying tissue where the drug exerts its prolonged localized anti-inflammatory and analgesic effect. For further information, visit the Company’s web site at www.transdelpharma.com.